4.6 Article

Atad2 is a generalist facilitator of chromatin dynamics in embryonic stem cells

Journal

JOURNAL OF MOLECULAR CELL BIOLOGY
Volume 8, Issue 4, Pages 349-362

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jmcb/mjv060

Keywords

FACT; epidrug; germ cells; cancer drug target; histone turnover; Pax3; histone chaperone

Categories

Funding

  1. INCa
  2. ANR EpiSperm2 project
  3. foundation ARC
  4. SGC, a registered charity [1097737]
  5. AbbVie
  6. Bayer
  7. Boehringer Ingelheim
  8. Canada Foundation for Innovation
  9. Canadian Institutes for Health Research
  10. Genome Canada
  11. GlaxoSmithKline
  12. Janssen
  13. Lilly Canada
  14. Novartis Research Foundation
  15. Ontario Ministry of Economic Development and Innovation
  16. Pfizer
  17. Takeda
  18. Wellcome Trust [092809/Z/10/Z]
  19. European Union [278568 'PRIMES']

Ask authors/readers for more resources

Although the conserved AAA ATPase and bromodomain factor, ATAD2, has been described as a transcriptional co-activator upregulated in many cancers, its function remains poorly understood. Here, using a combination of ChIP-seq, ChIP-proteomics, and RNA-seq experiments in embryonic stem cells where Atad2 is normally highly expressed, we found that Atad2 is an abundant nucleosome-bound protein present on active genes, associated with chromatin remodelling, DNA replication, and DNA repair factors. A structural analysis of its bromodomain and subsequent investigations demonstrate that histone acetylation guides ATAD2 to chromatin, resulting in an overall increase of chromatin accessibility and histone dynamics, which is required for the proper activity of the highly expressed gene fraction of the genome. While in exponentially growing cells Atad2 appears dispensable for cell growth, in differentiating ES cells Atad2 becomes critical in sustaining specific gene expression programmes, controlling proliferation and differentiation. Altogether, this work defines Atad2 as a facilitator of general chromatin-templated activities such as transcription.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available